HLA G Recombinant Antibody, PE-Cy7 Conjugated
Product Specifications
Background
Non-classical major histocompatibility class Ib molecule involved in immune regulatory processes at the maternal-fetal interface. In complex with B2M/beta-2 microglobulin binds a limited repertoire of nonamer self-peptides derived from intracellular proteins including histones and ribosomal proteins.
Synonyms
HLA G antigen; MHC class I antigen G; HLA-G; HLA60; HLAG.
Gene ID
3135
Swiss Prot
P17693
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
HLA G
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human HLA G
Applications
WB
Purification
Purified Polyclonal A
Excitation Emission
488nm/780nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
3135
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
1211538 1000 Pack
T220/230-6005, T-Reducer Connector, 200-Series-Barb, f. I-Ø 2.4/3.2 mm, PP, PU=1000 pieces
Ask
View Details 
MBS6146798-01 0.1 mL
DDIT4L (REDD2, RTP801L, DNA Damage-inducible Transcript 4-like Protein, HIF-1 Responsive Protein RTP801-like, Protein Regulated in Development and DNA Damage Response 2) (FITC)
Ask
View Details MBS6146798-02 5x 0.1 mL
DDIT4L (REDD2, RTP801L, DNA Damage-inducible Transcript 4-like Protein, HIF-1 Responsive Protein RTP801-like, Protein Regulated in Development and DNA Damage Response 2) (FITC)
Ask
View Details